P. Ruffié

发表

Phase I and pharmacokinetic study of docetaxel and irinotecan in patients with advanced solid tumors.

M. Ducreux, P. Rougier, J. Armand, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.

J. Soria, J. Pujol, J. Douillard, 2001, The oncologist.

A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.

M. Ducreux, E. Raymond, E. Baudin, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer.

R. Arriagada, T. Tursz, P. Berthaud, 1992, European journal of cancer.

Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.

R. Arriagada, T. le Chevalier, C. Le Péchoux, 1996, International journal of radiation oncology, biology, physics.

Pre-operative and post-operative treatments in stage III NSCLC.

R. Ginsberg, O. Brodin, D. Payne, 1994, Lung cancer.

Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.

T. Chevalier, T. le Chevalier, P. Barthélémy, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination o f R altitrexed a nd O xaliplatin I s a n A ctive Regimen i n M alignant M esothelioma: Results o f a P hase I I S tudy

T. Chevalier, K. Fizazi, H. Doubre, 2003 .

Surgery for lung metastases from colorectal cancer: analysis of prognostic factors.

B. Gayet, M. Ducreux, P. Rougier, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of vinflunine in malignant pleural mesothelioma.

D. Talbot, L. Ollivier, G. Dabouis, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

U. Gatzemeier, S. Emri, N. Vogelzang, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I II S tudy o f P emetrexed i n C ombination W ith C isplatin Versus C isplatin A lone i n P atients W ith M alignant P leural Mesothelioma

U. Gatzemeier, S. Emri, N. Vogelzang, 2003 .

Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease.

R. Arriagada, T. le Chevalier, J. Bignon, 1985, International journal of radiation oncology, biology, physics.

Relationship between tuberculous scar and carcinomas of the lung.

A. Hirsch, P. Ruffié, M. Bickel, 1987, European journal of radiology.

The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?

T. de Baère, M. Ducreux, T. Baère, 2004, European journal of cancer.

Impact of chromogranin A measurement in the work-up of neuroendocrine tumors.

E. Baudin, J. Bidart, M. Schlumberger, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Extensive small-cell lung cancer. A randomized comparison of two chemotheraphy programs with early crossover in instances of failure

T. Chevalier, E. Quoix, P. Chariot, 1992 .

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Claude Denham, Salih Emri, Nicholas J Vogelzang, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination raltitrexed (Tomudex(R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma.

J. Armand, T. le Chevalier, P. Soulié, 2000, European journal of cancer.

Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors.

E. Baudin, V. Lazar, J. Bidart, 1999, The Journal of clinical endocrinology and metabolism.

Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study.

M. Ducreux, C. Théodore, T. le Chevalier, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

BRONCHIQUE ’ évaluation du statut nutritionnel du patient uivi pour un cancer bronchique est un élément mportant de la prise en charge valuating the nutritional status of a lung cancer patient is an important lement in patient management

S. Antoun, M. Merad, P. Ruffié, 2008 .

Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma.

S. Novello, E. Raymond, J. Armand, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer.

N. Ibrahim, A. Monnier, J. Douillard, 1998, European journal of cancer.

[Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology].

S. Culine, C. Théodore, T. le Chevalier, 1997, Bulletin du cancer.

Systemic mastocytosis following mediastinal germ cell tumor: an association confirmed.

P. Gaulard, P. Chariot, I. Monnet, 1993, Human pathology.

Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a.

P. Terrier, J. Armand, T. Chevalier, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinoma.

P. Hérait, P. Rougier, C. Théodore, 1987, Cancer treatment reports.

Combined Etoposide, Ifosfamide, and Cisplatin in the Treatment of Patients with Advanced Thymoma and Thymic Carcinoma. A French Experience

P. Terrier, T. le Chevalier, N. Paleiron, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).

M. Riggi, E. Cvitkovic, L. Vergne, 1991, European journal of cancer.

Small cell lung cancer: patients surviving longer than thirty months. Groupe d'oncologie de langue française.

B. Milleron, E. Brambilla, D. Moro, 1994, Anticancer research.

Limited small cell lung cancer treated by combined radiotherapy and chemotherapy: evaluation of a grading system of lung fibrosis.

R. Arriagada, H. Mouriesse, D. Couanet, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients.

R. Arriagada, T. le Chevalier, H. de Thé, 1988, NCI monographs : a publication of the National Cancer Institute.

Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques)

M. Riggi, E. Cvitkovic, I. Monnet, 1993, European journal of cancer.

Primary mediastinal germ cell tumors. Results of a French retrospective study.

P. Diot, E. Lemarié, J. Droz, 1992, Chest.

Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?

S. Culine, C. Théodore, T. Chevalier, 1998, European journal of cancer.

Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.

M. Gottfried, A. Lecesne, L. Belli, 1995, Seminars in oncology.

Super-high-risk germ-cell tumors: a clinical entity

S. Culine, J. Droz, B. Escudier, 1994, Supportive Care in Cancer.

Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.

R. Ginsberg, Y. Cormier, R. Feld, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer.

M. Ducreux, J. Soria, J. Armand, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer.

J P Pignon, P Chomy, R. Arriagada, 1993, The New England journal of medicine.

[Neurotrichinosis: a case report with MRI evaluation].

A. Bonafe, M. De Graef, G. Bourbotte, 2000, Journal de radiologie.

Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.

S. Culine, C. Théodore, T. Chevalier, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose intensity of initial chemotherapy may have an impact on survival in limited small cell lung carcinoma

R. Arriagada, T. Chevalier, H. Sancho-garnier, 1993 .

Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group.

R. Arriagada, T. le Chevalier, P. Baldeyrou, 1990, International journal of radiation oncology, biology, physics.

Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma.

R. Arriagada, J. Douillard, T. le Chevalier, 1992, Journal of the National Cancer Institute.

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.

R. Arriagada, J. Douillard, T. Chevalier, 1991, Journal of the National Cancer Institute.

Pleural effusion: laboratory tests in 300 cases.

M. Nebut, J. Bignon, J. Chrétien, 1979, Thorax.

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.

E. Baudin, J. Bidart, M. Schlumberger, 1998, British Journal of Cancer.

Astro plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients

R. Arriagada, J. Pignon, J. Douillard, 1991 .

New therapeutic approaches in mesothelioma

M. Jaurand, J. Bignon, P. Ruffié, 1994 .

Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial

J. Merker, M. Liedtke, P. Westervelt, 2018, Leukemia.

[Neuroendocrine tumor of the trachea of the intermediate type. Value of its individualization].

E. Tartour, B. Caillou, M. Schlumberger, 1992, Presse medicale.

Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.

R. Arriagada, J. Douillard, T. le Chevalier, 1994, Lung cancer.

[Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)].

D. Planchard, B. Besse, F. Vaylet, 2011, Revue de pneumologie clinique.

Limited small cell lung cancer: possible prognostic impact of initial chemotherapy doses.

R. Arriagada, T. le Chevalier, H. de Thé, 1989, Bulletin du cancer.

PROPHYLACTIC CRANIAL IRRADIATION IN SMALL CELL LUNG CANCER

R. Arriagada, T. Chevalier, J. Dewar, 1985, The Lancet.

A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma

R. Arriagada, T. Tursz, T. le Chevalier, 1991, Cancer.

Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer.

R. Arriagada, T. le Chevalier, C. Le Péchoux, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.

R. Arriagada, T. le Chevalier, P. Ruffié, 1994, Lung cancer.

Triangular test and randomized trials: practical problems in a small cell lung cancer trial.

A. Auquier, R. Arriagada, J. Pignon, 1994, Statistics in medicine.

Experience of the Institut Gustave-Roussy in alternating radiotherapy and chemotherapy schedules as induction treatment in limited small-cell lung cancer.

R. Arriagada, T. le Chevalier, H. de Thé, 1988, Antibiotics and chemotherapy.

[Inoperable lung epidermoid cancer non metastasizing. A phase II trial using radiotherapy and combined chemotherapy].

R. Arriagada, T. le Chevalier, P. Duroux, 1985, Bulletin du cancer.

Major effect on survival of the first course of chemotherapy in limited small cell lung cancer

R. Arriagada, H. Sancho-garnier, P. Ruffié, 1989 .

Severe mucositis after chemotherapy with vinorelbine, 5-fluorouracil, leucovorin and cisplatin.

P. Chariot, E. Cvitkovic, I. Monnet, 1991, European journal of cancer.